Literature DB >> 29063437

Adherence in Atopic Dermatitis.

Nupur Patel1, Steven R Feldman2.   

Abstract

Atopic dermatitis is a chronic dermatologic condition requiring extended treatment times with topical application of medications. While atopic dermatitis treatments can be highly effective when used as directed, oftentimes patients do not respond as expected, raising concern for non-adherence versus non-response. This chapter aims to describe what is currently known about adherence in atopic dermatitis and to discuss strategies to improve adherence in order to improve treatment outcomes. Whether intentional or unintentional, non-adherence to treatment can limit patient outcomes of this disease for a variety of reasons. These include frustration with medication efficacy, inconvenience, and fear of side effects. Other factors include forgetfulness, financial burden of treatment, lack of trust in the physician, dislike of prescribed medication, or lack of understanding of disease or treatment. Several interventions have been studied with the aim of improving adherence in atopic dermatitis-such as educational workshops for patients and caregivers, earlier follow-up visits, and text messages reminders-however these are often limited by sample size and power. Further research is needed to study both specific patterns of nonadherence in atopic dermatitis, as well as methods to improve them.

Entities:  

Keywords:  Adherence; Atopic dermatitis; Compliance; Eczema; Patient education

Mesh:

Year:  2017        PMID: 29063437     DOI: 10.1007/978-3-319-64804-0_12

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  Distinguishing truly recalcitrant prurigo nodularis from poor treatment adherence: a response to treatment-resistant prurigo nodularis [Response to letter].

Authors:  Eric H Kowalski; Diana Kneiber; Manuel Valdebran; Umangi Patel; Kyle T Amber
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-05-23

2.  Treatment of non-atopic dermatitis with polarized UV-free polychromatic light: A case report.

Authors:  Alberto Leguina-Ruzzi; Kishan Rajnikant Raichura; Sarah Karis Tonks; Semira Kwabi; Claudia Leitner
Journal:  Clin Pract       Date:  2019-09-23

3.  Treatment Adherence Among Patients with Five Dermatological Diseases and Four Treatment Types - a Cross-Sectional Study.

Authors:  Najlaa Abdulrahman Alsubeeh; Aya Ahmed Alsharafi; Shaik Shaffi Ahamed; Abdulmajeed Alajlan
Journal:  Patient Prefer Adherence       Date:  2019-12-03       Impact factor: 2.711

4.  Dual Delivery of Fluticasone Propionate and Levocetirizine Dihydrochloride for the Management of Atopic Dermatitis Using a Microemulsion-Based Topical Gel.

Authors:  Saud Almawash; Sheikh Shahnawaz Quadir; Ahmed Al Saqr; Gajanand Sharma; Kaisar Raza
Journal:  ACS Omega       Date:  2022-02-28

Review 5.  The Challenge of Managing Atopic Dermatitis in the United States.

Authors:  Steven R Feldman; Linda S Cox; Lindsay C Strowd; Robert A Gerber; Steven Faulkner; Debra Sierka; Timothy W Smith; Joseph C Cappelleri; Mark E Levenberg
Journal:  Am Health Drug Benefits       Date:  2019-04

6.  Paediatric atopic eczema (atopic dermatitis) in South Africa: A practical algorithm for the management of mild-to-moderate disease in daily clinical practice.

Authors:  Susanna M Kannenberg; Sarah Karabus; Willem I Visser; Jamilabibi Aboobaker; Magdalena M Kriel; Michael Levin; Basil Magigaba; Ahmed Manjra; Rupesh Misra; Pholile Mpofu; Azwitamisi Tshigabe; Thomas Luger
Journal:  S Afr Fam Pract (2004)       Date:  2020-11-23

7.  Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic Dermatitis.

Authors:  Jonathan I Silverberg; Eric L Simpson; April W Armstrong; Marjolein S de Bruin-Weller; Alan D Irvine; Kristian Reich
Journal:  Am J Clin Dermatol       Date:  2021-10-26       Impact factor: 7.403

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.